|

SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment

RECRUITINGSponsored by HJN Sverige AB/Neko Health
Actively Recruiting
SponsorHJN Sverige AB/Neko Health
Started2024-07-01
Est. completion2026-06
Eligibility
Age58 Years – 72 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07001007

Summary

This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and pulse wave characteristics and explore its potential in assessment of coronary artery disease, aortic stenosis and heart failure, in a population-based sample aged 58-72 years. It will be the first in clinical setting, pilot stage, observational investigation to evaluate the clinical safety, performance and diagnostic accuracy of Cardio P4, a laser-doppler vibrometry (LDV) and microwave radar-based device.

Eligibility

Age: 58 Years – 72 YearsHealthy volunteers accepted
Inclusion Criteria:

* Subjects already included in the main / general SCAPIS 2 study at Danderyd Hospital in Stockholm, and of which has also participated in the echocardiography examination

Exclusion Criteria:

* Patients unable to provide an informed consent

Conditions5

Aortic Valve DiseaseArterial StiffnessCoronary Arterial Disease (CAD)Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.